Clinical and pathobiologic considerations in the evaluation of markers of myocardial ischemia

J E Adams1

  • 1Jewish Hospital Heart and Lung Institute, Louisville KY 40202, USA. jadams03@sprynet.com

Cardiovascular Toxicology
|September 6, 2002
PubMed

Insights

Developing blood tests for myocardial ischemia requires careful consideration of diverse causes. A single "marker for ischemia" is unlikely; situation-specific proteins and assays are more probable for detecting heart issues.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Ischemic Heart Disease

Background:

  • There is a critical need for blood-based assays to detect myocardial ischemia and identify at-risk patients.
  • Unstable angina has diverse etiologies and complex cellular interactions, complicating the search for a universal ischemia marker.

Purpose of the Study:

  • To explore the challenges and considerations in developing blood-based analytic techniques for detecting myocardial ischemia.
  • To discuss the limitations of a singular "marker for ischemia" and the potential need for situation-specific biomarkers.

Main Methods:

  • Review of existing literature on myocardial ischemia and biomarker discovery.
  • Analysis of the complexities in identifying proteins indicative of ischemia across various pathological conditions.
  • Discussion on the selection of appropriate gold standards for assay validation.

Main Results:

  • A single protein marker for all types of ischemia is improbable due to diverse etiologies.
  • A spectrum of situationally specific proteins and corresponding analytic assays will likely be necessary.
  • The selection of a gold standard is a crucial and challenging decision in assay development.

Conclusions:

  • Caution is advised when using the term "marker for ischemia" due to the complexity of the condition.
  • Future research should focus on identifying situation-specific biomarkers and validating assays rigorously.
  • Clinical trial data is essential to generalize the usefulness of any ischemia detection assay.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...